FDA Town Hall

Date

May 20, 2024

SOCIETY: AGA The AGA-FDA Town Hall provides health care professionals, clinical trial investigators, and other interested stakeholders an opportunity to hear directly from FDA representatives about the agency's thinking behind recent approvals, safety signals, guidance documents, and boxed warnings for GI drugs. This session was jointly developed by AGA and representatives of the Division of Gastroenterology at the FDA Center for Drug Evaluation and Research.

Moderators

Scott Harris

Middleburg Consultants

Colin Howden

University of Tennessee Health Science Center

General

Esophageal Diseases | Functional GI and Motility Disorders | Inflammatory Bowel Diseases

Tracks

AGA

Related Products

AGA Drivers and Triggers of Visceral Pain in Intestinal Inflammation

Visceral pain is a leading cause of disability worldwide, affecting 20% of the population. Increased sensitivity to normal innocuous stimuli in the intestine is a hallmark of many organic and functional gastrointestinal disorders…

AGA FDA Town Hall

This session was jointly developed by AGA and representatives from the Division of Gastroenterology at the FDA Center for Drug Evaluation and Research…

Neuroimmune Crosstalk in Gut Health and Disease

SOCIETY: AGA The intestine is the largest immune organ and is also heavily innervated by intrinsic and extrinsic neurons. Emerging data show multiple modes of interaction between cells of the nervous system (neurons and glia) and immune cells that impact both intestinal health and disease processes…

Tadataka â€œTachiâ€ Yamada, MD, Lecture: Food as Medicine: How to Utilize Diet and Enhance Nutrition to Improve Outcomes in Foregut Diseases

LIVE STREAM SESSION This session will review evidence-based dietary approaches to management of patients with common foregut diseases including gastroesophageal reflux disease, eosinophilic esophagitis, and motility disorders of the esophagus and stomach…